COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,384 Articles (22,816 medRxiv, 8,568 bioRxiv)

Most recent first Previous |  Page 203: Articles 2021-2030  | Next

Differential circulating proteomic responses associated with ancestry during severe COVID-19 infection
Zheng, T. M., Ilboudo, Y., Lu, T., Butler-Laporte, G., Nakanishi, T., Morrison, D., Adra, D., Richards, J. B.
10.1101/2024.07.09.24310087 — Posted: 2024-07-10
SARS-CoV-2 shedding dynamics in human respiratory tract
Jin, X., Ren, L., Ren, X., Wang, J.
10.1101/2024.07.09.602697 — Posted: 2024-07-09
Associations between social network characteristics and COVID-19 vaccination intention: the SaNAE study
Steijvers, L. C., van Bilsen, C. J., Brinkhues, S., Stutterheim, S. E., Crutzen, R., Ruiter, R. A., Hoebe, C. J., Dukers-Muijrers, N. H.
10.1101/2024.07.08.24309958 — Posted: 2024-07-08
SARS-CoV-2 neutralization and protection of hamsters via nasal administration of a humanized neutralizing antibody
Lebedin, M., Petrovsky, N., Tabynov, K., Tabynov, K., Lebedin, Y.
10.1101/2024.07.08.602557 — Posted: 2024-07-08
NSP4 mutation T492I drives rapid evolution of SARS-CoV-2 toward Omicron
Lin, X., Sha, Z., Zhang, C., Adler, J. M., Vidal, R. M., Langner, C., Fu, B., Xiong, Y., Tan, M., Jiang, C., Zeng, H., Zhang, X., Li, Q., Yan, J., Lu, X., Wang, S., Mao, X., Kunec, D., Trimpert, J., Wu, H., Zou, Q., Zhu, Z.
10.1101/2024.07.05.602217 — Posted: 2024-07-08
Early 2022 breakthrough infection sera from India target the conserved cryptic class 5 epitope to counteract immune escape by SARS-CoV-2 variants
Das Jana, I., Kanjo, K., Roy, S., Bhasin, M., Bhattacharya, S., Banerjee, I., Jana, S., Chatterjee, A., Chakraborty, A., Chakraborty, S., Mukherjee, B., Varadarajan, R., Mondal, A.
10.1101/2024.07.08.602485 — Posted: 2024-07-08
Structural impact of synonymous mutations in six SARS-CoV-2 Variants of Concern
Ziesel, A., Jabbari, H.
10.1101/2024.07.06.602340 — Posted: 2024-07-08
Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR Network Study
Nunes, B., Humphreys, J., Nicolay, N., Braeye, T., Van Evercooren, I., Hansen, C. H., Moustsen-Helms, I. R., Sacco, C., Fabiani, M. R., Castilla, J., Martinez-Baz, I., Meijerink, H., Machado, A., Soares, P., Ljung, R., Pihlstrom, N., Nardone, A., Bacci, S., Monge, S., VEBIS-EHR working group
10.1101/2024.07.04.24309832 — Posted: 2024-07-07
MENSA, a Media Enriched with Newly Synthesized Antibodies, to Identify SARS-CoV-2 Persistence and Latent Viral Reactivation in Long-COVID
Haddad, N. S., Morrison-Porter, A., Quehl, H., Capric, V., Lamothe, P. A., Anam, F., Runnstrom, M. C., Truong, A. D., Dixit, A. N., Woodruff, M. C., Chen, A., Park, J., Nguyen, D. C., Hentenaar, I., Kim, C. Y., Kyu, S., Stewart, B., Wagman, E., Geoffroy, H., Sanz, D., Cashman, K. S., Ramonell, R. P., Cabrera-Mora, M., Alter, D. N., Roback, J. D., Horwath, M. C., O'Keefe, J. B., Dretler, A. W., Gripaldo, R., Yeligar, S. M., Natoli, T., Betin, V., Patel, R., Vela, K., Hernandez, M. R., Usman, S., Varghese, J., Jalal, A., Lee, S., Le, S. N., Amoss, R. T., Daiss, J. L., Sanz, I., Lee, F. E.-H.
10.1101/2024.07.05.24310017 — Posted: 2024-07-07
A qualitative study exploring Emergency Department Staff attitudes to COVID-19 research
Quinn, J., Ho, A., Blunsum, A., Lowe, D. J.
10.1101/2024.07.04.24309781 — Posted: 2024-07-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).